Cosmetic safety guidance
This article was originally published in The Rose Sheet
Executive Summary
FDA should convene a panel of experts with no financial ties to the cosmetics industry to develop guidance on cosmetic safety substantiation, the Environmental Working Group says in a March 7 letter to Center for Food Safety & Applied Nutrition Director Robert Brackett. FDA reiterated a plan to develop a draft guidance to implement warning statements for cosmetic products containing ingredients not shown to be safe in a Feb. 3 letter to CTFA. Agency also said it would consider taking compliance action against firms marketing unsafe ingredients without warning labels, a measure EWG supports, the letter adds. Advocacy group filed a petition with FDA last year requesting the agency halt the unlawful distribution of misbranded, adulterated and unlabeled cosmetics (1"The Rose Sheet" June 14, 2004, p. 3)...
You may also be interested in...
Carcinogens In Cosmetics Need Oversight, Environmental Group Claims
Cosmetics manufacturers should reformulate products containing known or possible carcinogens and educate consumers on ingredient safety and alternatives to potentially harmful personal care products, according to Environmental Working Group, a non-profit research organization
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.